D.E. Shaw & Co’s Athira Pharma ATHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-30,049
Closed -$60.7K 3097
2023
Q3
$60.7K Sell
30,049
-20,719
-41% -$41.9K ﹤0.01% 2714
2023
Q2
$150K Sell
50,768
-12,706
-20% -$37.5K ﹤0.01% 2659
2023
Q1
$159K Sell
63,474
-88,670
-58% -$222K ﹤0.01% 2843
2022
Q4
$482K Buy
152,144
+24,022
+19% +$76.2K ﹤0.01% 2727
2022
Q3
$381K Buy
128,122
+107,162
+511% +$319K ﹤0.01% 2991
2022
Q2
$64K Buy
20,960
+4,438
+27% +$13.6K ﹤0.01% 3624
2022
Q1
$223K Sell
16,522
-37,178
-69% -$502K ﹤0.01% 3576
2021
Q4
$700K Buy
+53,700
New +$700K ﹤0.01% 2928